Abstract
EE447 Budget Impact Analysis of Tepotinib in England for Patients With Advanced Non-Small Cell Lung Cancer (aNSCLC) Harboring MET Exon 14 (METex14) Skipping
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have